PT - JOURNAL ARTICLE AU - Figueiredo, Flávio de Azevedo AU - Ramos, Lucas Emanuel Ferreira AU - Silva, Rafael Tavares AU - Pires, Magda Carvalho AU - Ponce, Daniela AU - de Carvalho, Rafael Lima Rodrigues AU - Schwarzbold, Alexandre Vargas AU - Maurílio, Amanda de Oliveira AU - Alves Scotton, Ana Luiza Bahia AU - Garbini, Andresa Fontoura AU - Farace, Bárbara Lopes AU - Garcia, Bárbara Machado AU - da Silva, Carla Thais Cândida Alves AU - Cimini, Christiane Corrêa Rodrigues AU - de Carvalho, Cíntia Alcantara AU - Dias, Cristiane dos Santos AU - Silveira, Daniel Vitorio AU - Manenti, Euler Roberto Fernandes AU - de Almeida Cenci, Evelin Paola AU - Anschau, Fernando AU - Aranha, Fernando Graça AU - de Aguiar, Filipe Carrilho AU - Bartolazzi, Frederico AU - Vietta, Giovanna Grunewald AU - Nascimento, Guilherme Fagundes AU - Noal, Helena Carolina AU - Duani, Helena AU - Vianna, Heloisa Reniers AU - Guimarães, Henrique Cerqueira AU - de Alvarenga, Joice Coutinho AU - Chatkin, José Miguel AU - de Moraes, Júlia Parreiras Drumond AU - Rugolo, Juliana Machado AU - Ruschel, Karen Brasil AU - Prado Martins, Karina Paula Medeiros AU - Menezes, Luanna Silva Monteiro AU - Couto, Luciana Siuves Ferreira AU - de Castro, Luís César AU - Nasi, Luiz Antônio AU - Cabral, Máderson Alvares de Souza AU - Floriani, Maiara Anschau AU - Souza, Maíra Dias AU - Souza e Silva, Maira Viana Rego AU - Carneiro, Marcelo AU - de Godoy, Mariana Frizzo AU - Bicalho, Maria Aparecida Camargos AU - Barbosa Lima, Maria Clara Pontello AU - Nogueira, Matheus Carvalho Alves AU - Martins, Matheus Fernandes Lopes AU - Guimarães-Júnior, Milton Henriques AU - Sampaio, Natália da Cunha Severino AU - de Oliveira, Neimy Ramos AU - Ziegelmann, Patricia Klarmann AU - Andrade, Pedro Guido Soares AU - Assaf, Pedro Ledic AU - de Lima Martelli, Petrônio José AU - Pereira, Polianna Delfino AU - Martins, Raphael Castro AU - Menezes, Rochele Mosmann AU - Francisco, Saionara Cristina AU - Araújo, Silvia Ferreira AU - Oliveira, Talita Fischer AU - de Oliveira, Thainara Conceição AU - Sales, Thaís Lorenna Souza AU - Ramires, Yuri Carlotto AU - Marcolino, Milena Soriano TI - Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients AID - 10.1101/2022.01.11.22268631 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.11.22268631 4099 - http://medrxiv.org/content/early/2022/01/13/2022.01.11.22268631.short 4100 - http://medrxiv.org/content/early/2022/01/13/2022.01.11.22268631.full AB - Background Acute kidney injury (AKI) is frequently associated with COVID-19 and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalized COVID-19 patients.Methods This study is part of the multicentre cohort, the Brazilian COVID-19 Registry. A total of 5,212 adult COVID-19 patients were included between March/2020 and September/2020. We evaluated four categories of predictor variables: (1) demographic data; (2) comorbidities and conditions at admission; (3) laboratory exams within 24 h; and (4) the need for mechanical ventilation at any time during hospitalization. Variable selection was performed using generalized additive models (GAM) and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. The accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Risk groups were proposed based on predicted probabilities: non-high (up to 14.9%), high (15.0 – 49.9%), and very high risk (≥ 50.0%).Results The median age of the model-derivation cohort was 59 (IQR 47-70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalization. The validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. Thirty-two variables were tested and four important predictors of the need for KRT during hospitalization were identified using GAM: need for mechanical ventilation, male gender, higher creatinine at admission, and diabetes. The MMCD score had excellent discrimination in derivation (AUROC = 0.929; 95% CI 0.918–0.939) and validation (AUROC = 0.927; 95% CI 0.911–0.941) cohorts an good overall performance in both cohorts (Brier score: 0.057 and 0.056, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/).Conclusion The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalized COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by Minas Gerais State Agency for Research and Development (Fundação de Amparo à Pesquisa do Estado de Minas Gerais –FAPEMIG) [grant number APQ–00208–20] and National Institute of Science and Technology for Health Technology Assessment (Instituto de Avaliação de Tecnologias em Saúde–IATS)/ National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico –CNPq) [grant number 465518/2014–1].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Brazilian National Committee for Ethics in Research - CONEP (CAAE - Certificate of presentation of Ethical Appreciation: 30350820.5.1001.0008)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAKIacute kidney injuryARDSacute respiratory distress syndromeAUROCarea under the receiver operating characteristicBMIbody mass indexBPM1beats per minuteBPM2breaths per minuteCIconfidence intervalCOPDchronic obstructive pulmonary diseaseCOVID-19Coronavirus disease 19GAMgeneralized additive modelsGBTgradient boosted treesICUintensive care unitIL-6interleukin-6IQRinterquartile rangeKDIGOKidney Disease Improving Global OutcomesKRTkidney replacement therapyLASSOleast absolute shrinkage and selection operatorMICEmultiple imputation with chained equationsMMCDmechanical ventilation, male, creatinine, diabetesMVmechanical ventilationpCO2partial pressure of carbon dioxidePEEPpositive end-expiratory pressurePMMPredictive mean matchingPO2partial pressure of oxygenPROBASTPrediction model Risk Of Bias Assessment ToolREDCapResearch Electronic Data CaptureSBPsystolic blood pressureSF ratioSpO2/FiO2 ratioSOFASepsis-related Organ Failure AssessmentTRIPODTransparent Reporting of a Multivariable Prediction Model for Individual Prediction or DiagnosisUSAUnited States of America